USPTO serial 99254492
BIO-TECHNE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 20, 2026
- Examiner
- PODESTA, GIDETTE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIO-TECHNE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MINNEAPOLIS, MN, US
MINNEAPOLIS, MN, US
MINNEAPOLIS, MN, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Courtney Thompson
Courtney Thompson Fredrikson & Byron, P.A.60 South Sixth StreetSuite 1500Minneapolis, MN 55402Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents and chemicals for scientific research, medical research, clinical research, life science research, laboratory research, pharmaceutical research, and diagnostic reagents for scientific use; reagents, namely recombinant proteins and antibodies, for scientific research, medical research, clinical research, life science research, laboratory research, pharmaceutical research, and diagnostic reagents for scientific use; biological cell culture media for scientific purposes and for research in the fields of medical, clinical, life science, laboratory and pharmaceutical research, biological cell culture media for diagnostic use for scientific purposes; assays for research purposes; fluorescent dyes for scientific purposes and for research in the fields of medical, clinical, life science, laboratory and pharmaceutical research, and for diagnostic use for scientific purposes; oligonucleotides for scientific purposes and for research in the fields of medical, clinical, life science, laboratory and pharmaceutical research, and for diagnostic use for scientific purposes; enzymes for scientific and research purposes. | ACTIVE | Nov 27, 2013 |
| 005 | Reagents and diagnostic reagents for clinical medical use; chemicals for clinical medical use, namely, for diagnosing, detecting, prognosing, stratifying or selecting therapy for a disease condition, including cancer and inherited genetic disorders; antibodies for medical purposes; proteins for medical diagnosis purposes; oligonucleotides for medical diagnostic purposes; culture media for cultivating human and animal cells for medical or clinical use; reagents and media for medical and veterinary diagnostic purposes; biological reagents, namely, clinical medical reagents; diagnostic preparations for medical use, namely, western blot. | ACTIVE | Sep 26, 2014 |
| 009 | Instrumentation for life science research, namely, instruments to identify, quantify, and characterize proteins, analyze particles in biological samples, perform immunoassays, and to dispense and characterize cells, namely, protein detection and analysis instruments being automated western blot and imaged capillary electrophoresis instruments, immunoassay instruments, cell sorter and single cell dispenser instruments, and cell and tissue imaging analysis systems; instrumentation for life science research, namely, instruments for quality control and analysis in the manufacture of therapeutic products in the nature of micro-flow imaging systems; multiplexers; microplate readers in the nature of apparatuses and instruments used to detect and measure assays in microtiter plates; microplate readers in the nature of apparatuses and instruments used to detect and measure absorbance at different light wavelengths for immunoassays; microplate readers in the nature of apparatuses and instruments used to detect and measure assays in plates for research, bioassays, drug discovery, and manufacturing; protein analysis equipment comprised of computer hardware, recorded software, and display screens for protein detection, imaging, and quantitative analysis for use in genetic research, antibody research, biomarker discovery, and biotherapeutics production; laboratory apparatus, namely, protein sample fractionators; computer hardware and peripherals; downloadable software for multiplexing; laboratory apparatus, namely, electrophoresis apparatus not for medical purposes, in particular for western blot processing. | ACTIVE | Nov 27, 2013 |
| 010 | Diagnostic apparatus for medical purposes used in medical laboratories, namely, electophoresis apparatus for western blot processing or automated Enzyme-linked Immunosorbent Assays (ELISAs) platforms for immunoassays. | ACTIVE | Oct 21, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BIO-TECHNE CORPORATION
- Other trademarks owned by BIO-TECHNE CORPORATION
- Other trademarks owned by BIO-TECHNE CORPORATION
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named BIO-TECHNE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 20, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 20, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 29, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 29, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 29, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 8, 2026 | IUAF | USE AMENDMENT FILED | — |
| Sep 8, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 10, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 13, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 13, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 7, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 16, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 15, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 15, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 15, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 16, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 8, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 26, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 26, 2025 | NWAP | NEW APPLICATION ENTERED | — |